Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) EBITDA Margin (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of EBITDA Margin data on record, last reported at 16.96% in Q4 2025.

  • For Q4 2025, EBITDA Margin rose 63.0% year-over-year to 16.96%; the TTM value through Dec 2025 reached 17.8%, down 29.0%, while the annual FY2025 figure was 18.58%, 24.0% up from the prior year.
  • EBITDA Margin reached 16.96% in Q4 2025 per PBH's latest filing, up from 15.64% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 21.4% in Q4 2023 and bottomed at 84.87% in Q1 2023.
  • Average EBITDA Margin over 5 years is 12.97%, with a median of 17.57% recorded in 2025.
  • Peak YoY movement for EBITDA Margin: crashed -10595bps in 2023, then soared 10058bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 18.74% in 2021, then grew by 14bps to 21.39% in 2022, then grew by 0bps to 21.4% in 2023, then decreased by -24bps to 16.33% in 2024, then increased by 4bps to 16.96% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 16.96% in Q4 2025, 15.64% in Q3 2025, and 21.19% in Q2 2025.